Ludwig Boltzmann - Institute for Applied Cancer Research [clinicaltrials_resource:06194bf129701996e351168bfcf8ec2e]
Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer [clinicaltrials:NCT00002903]MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003028]Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00005980]
location [clinicaltrials_vocabulary:location]
Ludwig Boltzmann - Institute for Applied Cancer Research [clinicaltrials_resource:06194bf129701996e351168bfcf8ec2e]
Bio2RDF identifier
06194bf129701996e351168bfcf8ec2e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:06194bf129701996e351168bfcf8ec2e
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:06194bf129701996e351168bfcf8ec2e
title
Ludwig Boltzmann - Institute for Applied Cancer Research
@en
type
label
Ludwig Boltzmann - Institute f ...... 94bf129701996e351168bfcf8ec2e]
@en